Literature DB >> 16304362

Hereditary periodic fever syndromes.

Daniel L Kastner1.   

Abstract

The hereditary periodic fevers are a group of Mendelian disorders characterized by seemingly unprovoked fever and localized inflammation. Recent data indicate that these illnesses represent inborn errors in the regulation of innate immunity. Pyrin, the protein mutated in familial Mediterranean fever, defines an N-terminal domain found in a large family of proteins involved in inflammation and apoptosis. Through this domain pyrin may play a role in the regulation of interleukin (IL)-1beta, nuclear factor (NF)-kappaB, and leukocyte apoptosis. Cryopyrin/NALP3, another protein in this family, is mutated in three other hereditary febrile syndromes and participates in the inflammasome, a newly recognized macromolecular complex crucial to IL-1beta activation. Somewhat unexpectedly, mutations in the 55 kDa receptor for tumor necrosis factor also give rise to a dominantly inherited periodic fever syndrome, rather than immunodeficiency, a finding that has stimulated important investigations into both pathogenesis and treatment. Finally, the discovery of the genetic basis of the hyperimmunoglobulinemia D with periodic fever syndrome suggests an as yet incompletely understood connection between the mevalonate pathway and the regulation of cytokine production. These insights extend our understanding of the regulation of innate immunity in man, while providing the conceptual basis for the rational design of targeted therapies, both for the hereditary periodic fevers themselves and other inflammatory disorders as well.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16304362     DOI: 10.1182/asheducation-2005.1.74

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  18 in total

1.  "Mutation negative" familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies.

Authors:  C M Hedrich; N Bruck; D Paul; G Hahn; M Gahr; A Rösen-Wolff
Journal:  Rheumatol Int       Date:  2011-07-22       Impact factor: 2.631

2.  Clinical and genetic features of hereditary periodic fever syndromes in Hispanic patients: the Chilean experience.

Authors:  Cristian Vergara; Arturo Borzutzky; Miguel A Gutierrez; Sergio Iacobelli; Eduardo Talesnik; María E Martinez; Lilith Stange; Javier Basualdo; Viviana Maluje; Renato Jimenez; Roberto Wiener; Javier Tinoco; Elena Jarpa; Juan I Aróstegui; Jordi Yagüe; Manuel Alvarez-Lobos
Journal:  Clin Rheumatol       Date:  2012-01-28       Impact factor: 2.980

3.  Pilot study: possible association of IL10 promoter polymorphisms with CRMO.

Authors:  J Hamel; D Paul; M Gahr; C M Hedrich
Journal:  Rheumatol Int       Date:  2011-01-15       Impact factor: 2.631

Review 4.  Redox stress unbalances the inflammatory cytokine network: role in autoinflammatory patients and healthy subjects.

Authors:  Rosa Lavieri; Anna Rubartelli; Sonia Carta
Journal:  J Leukoc Biol       Date:  2015-07-21       Impact factor: 4.962

Review 5.  CAPS--pathogenesis, presentation and treatment of an autoinflammatory disease.

Authors:  Jasmin B Kuemmerle-Deschner
Journal:  Semin Immunopathol       Date:  2015-05-12       Impact factor: 9.623

6.  [Cryopyrin-associated periodic syndrome].

Authors:  J B Kümmerle-Deschner
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

7.  Symptomatic patients with P369S-R408Q mutations: familial Mediterranean fever or mixed auto-inflammatory syndrome?

Authors:  Kristen Davies; Bradley Lonergan; Rikesh Patel; Marwan Bukhari
Journal:  BMJ Case Rep       Date:  2019-07-01

Review 8.  Canakinumab in patients with cryopyrin-associated periodic syndrome: an update for clinicians.

Authors:  Jasmin B Kuemmerle-Deschner; Iris Haug
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-12       Impact factor: 5.346

Review 9.  Fever tree revisited: From malaria to autoinflammatory diseases.

Authors:  Serena Pastore; Josef Vuch; Anna Monica Bianco; Andrea Taddio; Alberto Tommasini
Journal:  World J Clin Pediatr       Date:  2015-11-08

10.  The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1β and IL-18 production.

Authors:  Deepti Verma; Eva Särndahl; Henrik Andersson; Per Eriksson; Mats Fredrikson; Jan-Ingvar Jönsson; Maria Lerm; Peter Söderkvist
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.